Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhangzhou Innoessen Biotechnology is a specialized life sciences company focused on the research, development, and large-scale manufacturing of high-end biological reagents and raw materials. Based in China, the company provides critical components for cell therapy, molecular diagnostics, and vaccine production, including animal-free recombinant enzymes and GMP-grade cytokines. Their core product portfolio features recombinant trypsin, proteinase K, and various interleukins such as IL-2 and IL-15, all designed to meet stringent clinical-grade bioprocessing standards. Innoessen operates state-of-the-art GMP facilities to ensure the quality, safety, and scalability of their protein expression services. The company serves as a key supplier and CDMO partner for global biopharmaceutical and diagnostic firms seeking high-purity biological tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhangzhou Innoessen Biotechnology.